“…Treatment typically involves supportive care, including volume resuscitation, dietary modifications, pro-kinetic or antiemetic medications, surgery, and treatment of underlying malignancy [ 1 - 3 ]. For AL amyloidosis, as it is commonly caused by plasma cell dyscrasias, autologous stem cell transplant or chemotherapy with a combination of melphalan, bortezomib, and dexamethasone is associated with increased survival [ 1 , 2 , 5 ]. The prognosis of patients with amyloidosis and GI involvement appears worse than those without GI involvement [ 1 ].…”